Context Therapeutics Stock In The News
| CNTX Stock | USD 1.01 0.03 3.06% |
Our overall analysis of Context Therapeutics' news coverage and content from conventional and social sources shows investors' bearish mood towards Context Therapeutics. The specific impact of Context Therapeutics news on its stock price will depend on a range of factors, including the nature and significance of the news report and investors' perceptions of Context Therapeutics' overall financial health and prospects. It also depends on the type and quality of a news publisher.
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using Context Therapeutics headlines in addition to utilizing other, more conventional financial analysis modules. Check out Context Therapeutics Backtesting and Context Therapeutics Hype Analysis. For more information on how to buy Context Stock please use our How to Invest in Context Therapeutics guide.
Context |
Context Therapeutics Today Top News and Investor Outlook
Context Therapeutics Past News Timeline
Popular news outlets such as MarketWatch, Bloomberg, or Reuters provide Context and other traded companies coverage with news coverage. We help investors stay connected with Context headlines for the 18th of January 2025 to make an informed investment decision based on correlating the impacts of news items on Context Stock performance. Please note that trading solely based on the Context Therapeutics hype is not for everyone as timely availability and quick action are needed to avoid losses.
Context Therapeutics stock price changes are notoriously difficult to predict based exclusively on its news coverage or social hype. Still, the Context earnings-per-share ratio is a good starting point for gauging a company's future prospects. If a firm's EPS rises and meets or even beats consensus forecasts, its shares stand to increase. However, some very sophisticated investors can spot management manipulation of EPS through actions such as buybacks.
Far too much social signal, news, headlines, and media speculation about Context Therapeutics that are available to investors today. That information is available publicly through Context media outlets and privately through word of mouth or via Context internal channels. However, regardless of the origin, that massive amount of Context data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Context Therapeutics news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Context Therapeutics relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Context Therapeutics' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Context Therapeutics alpha.
Context Largest EPS Surprises
Earnings surprises can significantly impact Context Therapeutics' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2024-08-08 | 2024-06-30 | -0.0667 | -0.04 | 0.0267 | 40 | ||
2023-11-09 | 2023-09-30 | -0.31 | -0.37 | -0.06 | 19 | ||
2023-05-10 | 2023-03-31 | -0.34 | -0.4 | -0.06 | 17 | ||
2024-03-21 | 2023-12-31 | -0.35 | -0.42 | -0.07 | 20 | ||
2023-03-22 | 2022-12-31 | -0.295 | -0.22 | 0.075 | 25 | ||
2023-08-10 | 2023-06-30 | -0.2 | -0.31 | -0.11 | 55 |
Context Therapeutics Stock Latest Headlines
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using conventional financial analysis. Below is the latest headlines and news related to Context Therapeutics Stock. Current markets are strongly bullish. About 79% of major world exchanges and indexes are currently up. See today's market update for more information.
14th of January 2025
Context Therapeutics Announces First Patient Dosed in the Phase 1 Clinical Trial of CTIM-7... at gurufocus.com
13th of January 2025
Insider Trading at gurufocus.com
2nd of December 2024
Context Therapeutics Secures Funding for Cancer Therapy Pipeline - TipRanks at news.google.com
27th of November 2024
Context Therapeutics Inc. Stock Position Lessened by Great Point Partners LLC - MarketBeat at news.google.com
6th of November 2024
Context Therapeutics Reports Third Quarter 2024 Operating and Financial Results at globenewswire.com
23rd of October 2024
Context Therapeutics to Participate in Upcoming Investor Conferences in November at finance.yahoo.com
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Context Therapeutics in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Context Therapeutics' short interest history, or implied volatility extrapolated from Context Therapeutics options trading.
Additional Tools for Context Stock Analysis
When running Context Therapeutics' price analysis, check to measure Context Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Context Therapeutics is operating at the current time. Most of Context Therapeutics' value examination focuses on studying past and present price action to predict the probability of Context Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Context Therapeutics' price. Additionally, you may evaluate how the addition of Context Therapeutics to your portfolios can decrease your overall portfolio volatility.